Expects to maintain "mid-threes" debt/EBITDA ratio over next few years. Expects "modest" share repurchases in 2024/2025.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS:
Expects to maintain "mid-threes" debt/EBITDA ratio over next few years. Expects "modest" share repurchases in 2024/2025.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS: